Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Thrombocytopenia Occurrence With NxStage vs. Prismaflex Continuous Renal Replacement Systems

Khorsan R. Thrombocytopenia Occurrence With NxStage vs. Prismaflex Continuous Renal Replacement Systems. Cureus. 2025 Dec 19;17(12):e99659. doi: 10.7759/cureus.99659. PMID: 41561238; PMCID: PMC12812480.

Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide

Neinast M, Zuckerman JE, Khorsan R, Nobakht N, Kamgar M, Sarkar M, Kamal F, Arman F. Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide. Kidney[...]

Reuse of a Living Donor Kidney: A Case Study

Yin Y, Prewitt F, Nguyen J, Tao J, Pham PT, Kendrick E, Nassiri N, Veale JL, Reed EF, Hickey MJ. Reuse of a Living Donor[...]